Form 3 Filing: Initial Statement of Beneficial Ownership of Securities for Jyong Biotech Ltd.

This filing reports the initial beneficial ownership of securities for Jyong Biotech Ltd. (MENS) as of April 8, 2026. Fu-Feng Kuo, identified as the CEO and a 10% owner, has reported beneficial ownership of 25,349,500 ordinary shares. These shares are held indirectly through Perfect Minds Co., Ltd., a Seychelles company wholly owned by Innovation Global Group Limited. The ultimate control rests with Ms. Kuo, who has sole voting and dispositive power over these shares by virtue of her authority to direct voting and investment decisions for Perfect Minds. The filing also details the ownership structure involving The Innovation Trust and its trustee, Unity Trust Limited, with Ms. Kuo as the Settlor, Appointor, and an eligible beneficiary.